Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Sandwich, Kent CT13 9NJ, United Kingdom
Ketalar 10 mg/ml Injection.
| Pharmaceutical Form |
|---|
|
Solution for Injection or Infusion. A clear solution for injection or infusion. |
Each 1 ml of solution contains: ketamine hydrochloride equivalent to 10 mg ketamine base per ml.
Excipient(s) with known effect: Each 1 ml contains 2.6 mg of sodium.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ketamine |
Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist into the recovery period. |
| List of Excipients |
|---|
|
Sodium chloride |
20 ml white neutral glass vial with rubber closure and aluminium flip-off cap containing 20ml of solution as 10 mg ketamine base per ml.
Pfizer Limited, Sandwich, Kent CT13 9NJ, United Kingdom
PL 00057/0529
1st July 2003
| Drug | Countries | |
|---|---|---|
| KETALAR | Canada, Finland, Hong Kong, Ireland, Japan, New Zealand, Poland, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
